Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Feasibility of ROBERT-SAS in Severely Impaired Stroke Patients

NCT05421910 is registered in ClinicalTrials.gov with Roessingh Research and Development as lead sponsor.

NCT NCT05421910
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05421910 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Feasibility of ROBERT-SAS in Severely Impaired Stroke Patients
Lead sponsor
Roessingh Research and Development
Phase
Not applicable
Overall status
Completed
Start date
July 11, 2022
Completion date
August 24, 2023
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stroke